drugset / Trial / NCT05679037

Role of Alpha-lipoic Acid in Diabetes Melitus Type 1

NCT05679037

Phase 3 Unknown 52 enrolled Tanta University
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims at investigating the possible effect of alpha-lipoic acid on endothelial dysfunction and atherosclerosis in children with type 1 diabetes mellitus.

Timeline

Start
2023-01
Primary completion
2024-10
Completion
2024-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator alpha-lipoic acid Small molecule 600 mg Oral